According to Gram Research analysis, Shanhuang Jiangzhi tablets significantly reduced atherosclerotic plaque development in mice by shifting immune cells from a harmful inflammatory state to a protective anti-inflammatory state, while blocking a cellular pathway that normally drives plaque formation. However, this is early laboratory and animal research—human studies are needed before any medical recommendations can be made.
Researchers tested a traditional Chinese herbal supplement called Shanhuang Jiangzhi tablets to see if it could help prevent atherosclerosis, a condition where plaque builds up in arteries and increases heart disease risk. Using laboratory studies and mice with a genetic predisposition to heart disease, scientists found that the supplement reduced plaque buildup, improved how the body handles cholesterol, and calmed down harmful inflammation in immune cells. The supplement worked by blocking a specific pathway in the body that normally triggers inflammation and plaque formation. While these early results are encouraging, human studies are needed before doctors can recommend this treatment.
Key Statistics
A 2026 laboratory study found that Shanhuang Jiangzhi tablets significantly reduced atherosclerotic lesion development in genetically predisposed mice by modulating immune cell behavior and suppressing the ROS/TLR4/NF-κB inflammatory pathway.
Research showed that the herbal supplement shifted macrophage immune cells from a pro-inflammatory M1 state to an anti-inflammatory M2 state, reducing their tendency to form foam cells that accumulate in arterial plaques.
The study demonstrated that Shanhuang Jiangzhi tablets improved cholesterol metabolism in mice by increasing expression of ABCA1 and ABCG1 proteins, which help remove excess cholesterol from cells and tissues.
The Quick Take
- What they studied: Whether a traditional herbal supplement called Shanhuang Jiangzhi tablets could reduce atherosclerosis (plaque buildup in arteries) by changing how immune cells behave and preventing them from becoming foam cells that contribute to plaques.
- Who participated: The study used laboratory mice genetically prone to heart disease and cultured immune cells (macrophages) in test tubes. No human participants were involved in this early-stage research.
- Key finding: The herbal supplement significantly reduced atherosclerotic plaque development in mice, improved cholesterol metabolism, and shifted immune cells from a harmful inflammatory state to a protective anti-inflammatory state by blocking a specific cellular pathway.
- What it means for you: This is promising early research suggesting the supplement may help prevent heart disease, but it’s not ready for human use yet. Much more testing in humans is needed before any recommendations can be made. Do not use this supplement to treat heart disease without consulting your doctor.
The Research Details
This was a laboratory and animal study published in 2026 that tested Shanhuang Jiangzhi tablets using two main approaches. First, researchers used mice that were genetically engineered to develop atherosclerosis naturally, similar to how some humans develop heart disease. They gave some mice the herbal supplement and compared their artery health to mice that didn’t receive it.
Second, the team conducted detailed laboratory experiments using isolated immune cells called macrophages. They exposed these cells to substances that normally trigger inflammation and plaque formation, then tested whether the herbal supplement could prevent this harmful process. The researchers measured multiple markers of inflammation, cholesterol handling, and cellular changes to understand exactly how the supplement worked.
This type of research is called “preclinical” because it happens in laboratories and animals before any human testing. It’s an important first step to understand whether a treatment might be safe and effective enough to eventually test in people.
This research approach matters because it identifies the specific biological mechanisms—the actual steps in the body—that cause atherosclerosis. By understanding exactly how the supplement blocks harmful processes at the cellular level, scientists can better predict whether it might work in humans and identify potential side effects. The combination of animal studies and laboratory cell studies provides stronger evidence than either approach alone.
Strengths of this study include testing the supplement in multiple ways (in living animals and in isolated cells) and measuring multiple markers of disease. The research was published in a peer-reviewed journal, meaning other scientists reviewed it for quality. Limitations include that no human participants were involved, the sample size of mice wasn’t specified, and the study was conducted in laboratory conditions that don’t perfectly match real human biology. This is early-stage research that requires follow-up human studies before any clinical recommendations.
What the Results Show
In mice with atherosclerosis, the Shanhuang Jiangzhi supplement significantly reduced the size and extent of plaque buildup in arteries compared to untreated mice. The supplement also improved how the mice’s bodies handled cholesterol, specifically by increasing the activity of two important proteins (ABCA1 and ABCG1) that help remove excess cholesterol from cells and tissues.
At the cellular level, the supplement changed how immune cells called macrophages behave. These cells normally become “foam cells” that accumulate cholesterol and form the core of arterial plaques. The supplement shifted macrophages away from a harmful inflammatory state (called M1) toward a protective anti-inflammatory state (called M2), essentially making them less likely to contribute to plaque formation.
The research revealed that the supplement works by blocking a specific cellular communication pathway called ROS/TLR4/NF-κB. This pathway normally triggers inflammation and plaque development. By suppressing this pathway, the supplement reduced the production of harmful molecules called reactive oxygen species (ROS) that fuel inflammation and plaque growth.
Additional findings showed that the supplement reduced the activation of several key proteins involved in the inflammatory pathway, including TLR4, MYD88, and phosphorylated NF-κB p65. These are the specific molecular switches that normally turn on the inflammatory response. By turning down these switches, the supplement essentially quiets the cellular alarm system that drives atherosclerosis progression.
This research builds on existing knowledge that macrophage behavior and foam cell formation are critical steps in atherosclerosis development. Previous studies identified the ROS/TLR4/NF-κB pathway as a major driver of this process. This study is notable because it demonstrates that a traditional herbal supplement can effectively target this pathway, offering a different approach than many modern pharmaceutical treatments. The results align with and extend previous research showing that modulating immune cell behavior can reduce atherosclerosis.
This study has several important limitations. First, it was conducted entirely in laboratory settings and mice, not in humans, so results may not translate directly to people. Second, the specific sample size of mice used wasn’t reported, making it harder to assess statistical reliability. Third, the study doesn’t address potential side effects, drug interactions, or optimal dosing in humans. Fourth, mice with genetic atherosclerosis don’t perfectly mirror how the disease develops in humans with multiple risk factors. Finally, the supplement’s long-term safety and effectiveness remain unknown. Human clinical trials are essential before any medical recommendations can be made.
The Bottom Line
Based on this early research, Shanhuang Jiangzhi tablets show potential as a future atherosclerosis treatment, but confidence in this recommendation is currently LOW because human studies haven’t been conducted. Do not use this supplement to treat or prevent heart disease without explicit guidance from your doctor. If you’re interested in preventing atherosclerosis, focus on proven strategies: maintain a healthy diet, exercise regularly, manage stress, avoid smoking, and work with your healthcare provider on cholesterol and blood pressure management.
This research is most relevant to cardiovascular researchers, pharmaceutical companies, and traditional medicine scientists exploring new treatments. People with atherosclerosis or high heart disease risk should be aware of this emerging research but should not change their current treatment plans based on these findings. Anyone considering using this supplement should consult their cardiologist or primary care doctor first.
This is very early-stage research. If the supplement moves forward, human clinical trials would typically take 5-10 years before any potential approval for medical use. Even if human studies are successful, it would likely be several more years before the supplement becomes widely available as a treatment. For now, proven heart disease prevention strategies remain your best option.
Frequently Asked Questions
Can I use Shanhuang Jiangzhi tablets to prevent heart disease?
Not yet based on current evidence. This 2026 study only tested the supplement in mice and laboratory cells, not humans. Extensive human clinical trials are required before any medical recommendations can be made. Consult your doctor before using any supplement for heart disease prevention.
How does Shanhuang Jiangzhi work to reduce atherosclerosis?
The supplement blocks a cellular pathway called ROS/TLR4/NF-κB that normally triggers inflammation and plaque formation. It also shifts immune cells called macrophages from a harmful inflammatory state to a protective anti-inflammatory state, reducing their contribution to arterial plaques.
What are the proven ways to prevent atherosclerosis right now?
Established prevention strategies include maintaining a heart-healthy diet rich in vegetables and whole grains, exercising 150 minutes weekly, managing stress, avoiding smoking, and keeping cholesterol and blood pressure at healthy levels. Work with your doctor to develop a personalized prevention plan.
When will Shanhuang Jiangzhi be available as a heart disease treatment?
This is very early research. If human trials begin soon, it would typically take 5-10 years for potential approval, with several additional years before widespread availability. Proven prevention strategies remain your best current option for reducing atherosclerosis risk.
Why do researchers study how immune cells contribute to heart disease?
Macrophages and foam cells are key drivers of plaque formation and rupture. Understanding how to control these cells offers a new approach to preventing atherosclerosis. This research identifies specific cellular pathways that could be targeted with future treatments.
Want to Apply This Research?
- If you’re interested in monitoring atherosclerosis risk factors while this research develops, track your weekly average cholesterol levels (if you have home testing), blood pressure readings, and dietary adherence to heart-healthy eating patterns. Record these metrics weekly in your health app.
- Use the app to set reminders for proven atherosclerosis prevention habits: 150 minutes of moderate exercise weekly, daily intake of heart-healthy foods (vegetables, whole grains, fish), and stress management activities like meditation. Create a dashboard showing progress toward these evidence-based goals.
- Establish a long-term tracking system that monitors your cardiovascular health markers quarterly through your doctor’s office (cholesterol panel, blood pressure, weight). Use the app to log lifestyle factors that influence these markers and identify patterns. Share quarterly reports with your healthcare provider to adjust prevention strategies as needed.
This research describes early-stage laboratory and animal studies only. Shanhuang Jiangzhi tablets have not been tested in humans and are not approved by the FDA for treating or preventing atherosclerosis or heart disease. Do not use this supplement to treat cardiovascular disease without explicit approval from your healthcare provider. This article is for informational purposes only and should not replace professional medical advice. If you have atherosclerosis, heart disease, or cardiovascular risk factors, consult your cardiologist or primary care physician before making any changes to your treatment or prevention plan. Proven strategies for atherosclerosis prevention include diet, exercise, stress management, and medications prescribed by your doctor.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.